Key Takeaways
- A tough quarter, with a transitory narrative: India volumes were flat and EBITDA fell 21% as palm oil inflation, urban slowdown and a poor HI season converged. Management expects sequential improvement in Q4 and margin recovery by H1 FY26.
- Palm oil is the central margin story: Unprecedented input inflation forced sharp price increases and trade destocking, compressing India EBITDA. The company is not done with pricing and needs 24-26% margins to return.
- RNF is the big strategic bet, still unproven: The new Household Insecticide formulation is rolling out with high awareness and early share gains, but management says it needs until March to really judge success.
- International held the line: Indonesia delivered 6% volume and 12% EBITDA growth; Africa margins reached mid-teens; Latin America volumes grew over 25%. GAUM is expected to return to positive organic revenue growth in Q4.
- What to watch next quarter: Whether Q4 volumes actually recover, how much further soap pricing is taken, and the first full-season read on RNF market share.
India Business: What Went Wrong
- Flat volumes, 4% revenue growth, 21% EBITDA decline: Three forces hit simultaneously: a macro-driven urban consumption slowdown, sharp price increases (including grammage cuts and trade scheme reductions) that triggered destocking, and a poor season in Household Insecticides. The bottom line also faced a high base from Q3 FY24.
- Urban weakness is real and broad: Modern trade slowed, urban general trade is under pressure, and premium products are not growing as fast. Some down-trading is visible in Household Insecticides. Quick commerce is growing fast but partly at the expense of other e-commerce, so the overall urban picture is weaker than the past.
- Rural is the bright spot: Rural growth is significantly ahead of urban, driven by the van program. First-half volumes grew close to 7% with vans contributing substantially. Q3 volumes were flat, but full-year volumes remain very good in the context of the market.
- Soap pricing is not finished: Q3 pricing was mid-single digit and does not yet reflect the full impact of actions taken. Management expects Q4 pricing growth to be higher and says one or two more rounds are needed to return to normative margins of 24-26%.
- Green shoots exist: Household Insecticides is on a good trajectory despite the quarter; the company is gaining rapid market share in Incense Sticks; Electrics started gaining share; Laundry, Air Fresheners and Sexual Wellness continue double-digit volume growth; Soaps revenue near flat is market-beating with EBITDA margins at approximately 20%.
Sitapati: "Q3 FY '25 has been a tough quarter for GCPL. In particular, our India business has had a poor performance, which has been somewhat compensated by our International business."
Palm Oil & Margin Math
- The inflation mechanism: Palm oil prices rose sharply, but the PFAD derivative used in soaps has not fallen in line. Palm oil corrected approximately 20% from its peak while PFAD fell only 7-8%, partly due to biodiesel dynamics and India import duty complications. Management expects this divergence to normalize over time.
- Q4 margin outlook is muted: Q4 will consume oil bought in Q3 (when prices were high), so margins may be "more of the same." Some price increases have been taken, but the full benefit will lag.
- The recovery path: Management expects soap margins to normalize over the next 2-3 quarters. By H1 of next year, margin growth should start to appear. For full-year FY26, unless oil prices change dramatically, the lower end of the 24-26% India margin band is a reasonable assumption.
- No other significant inflation pockets: Beyond palm oil, nothing material is flagged.
- Palm oil seasonality risk: The current period is the lean season in Malaysia and Indonesia; it is unclear whether the palm correction is temporary. B40 implementation in Indonesia adds further uncertainty. If palm stays lower, PFAD must eventually fall.
Sitapati: "I think there is requirement for another round of pricing in Soaps in particular... we are not done with the pricing because at the end of the day, we have to get back to our nominative margins."
RNF: The Household Insecticides Bet
- What RNF is: A new-molecule formulation for Liquid Vaporizers, launched end-July and rolled out sequentially by region and season. The proposition is sold as "works even if electricity goes off for 2 hours." Machine design was also changed, not just packaging.
- Rollout status: 40-50% of end-consumer offtakes are now the new formulation. Modern trade, approximately 20-25% of the business, still carries old stock because licenses took approximately 6 months and are only now coming through. Every month, the offtake proportion rises by about 10%.
- Early signals are encouraging: A dipstick shows consumer awareness is very high, with ad recall, investment recall and message recall all above benchmarks. November market shares were good; December was even better. The company is gaining significant market share in machines.
- Incense Sticks RNF is working: Launched in February last year, only in Q3 could management decisively say it is working. Share is now in high single digits, with share of handler close to 50% despite distribution only in the late teens.
- The verdict is still pending: Management says it will only be by March, when the next season comes, that it really gets a sense of how well RNF is working. Old product manufacturing for certain modern trade chains and e-commerce should be phased out by March.
- Aerosols next: A superior RNF formulation on Aerosols is launching now.
Sitapati: "We do a dipstick. We just did one to check the awareness of the product, and it is very high. The awareness of the product is high. November market shares were good, December was even better. So I feel we'll just have to give this a few more months to call this."
International: The Offset
- Indonesia solid: 6% volume growth, 9% revenue growth, 12% EBITDA growth. Household Insecticides optical softness this quarter was due to an El Nino bumper season last year in Q3; nothing structural on a two-year CAGR basis. Growth is now driven primarily by Electrics.
- Africa margins at an inflection point: Bottom-line performance continued with 9% growth, though revenues declined 8%. EBITDA margins are at approximately 15%, with scope for another 100-200 bps increase. Having reached mid-teens, the focus now shifts to growth.
- GAUM turning the corner: Organic revenue growth is expected to turn positive in Q4 FY25.
- Latin America strong: Volume growth over 25% and EBITDA margins now in double digits.
- Argentina and Nigeria: Suffered from poor macros.
Sitapati: "We were quite brutal about getting to this mid-high teens kind of margins and even if it came at the cost of business, we said, it doesn't matter. Having now got to this kind of margin structure, I guess we've got to start growing now."
Portfolio Moves & Distribution
- Soap competitive dynamics: The company was leading on pricing in the first six months; now everyone in the category has taken up prices. Management believes GCPL is growing faster than the market even this quarter. Nothing has changed on TFM or other claims.
- Body Wash: behind the curve: Management is candid that the company is behind on Body Wash, a category that is growing fast but remains a fraction of the overall soap market. Actions taken in the next few years are expected to deliver a fair share by the time Body Wash becomes substantial.
- Laundry Liquids a win: Godrej Fab is one of the most successful innovations, winning market share even in Q3. Investments in Fab are paying off in overall liquids including Ezee. Exponential growth is expected to continue, led by Tamil Nadu and the South.
- Deodorants: a self-inflicted wound: The company made a mistake in merging two distribution systems; they have now been separated. The portfolio is gaining share in modern trade but losing in general trade. Profitability is behind the business case and commitments inherited from RCCL.
- Urban GT distribution reset: Urban general trade, especially in metros, is a problem. To improve distributor ROI to 20-30%, the company will consolidate, reduce inventory, and may reduce distributor count (e.g., 30 to 20-22 in Bombay), moving toward zero inventory.
- Incense Sticks wholesale strategy: Once 20% value-weighted distribution is crossed, the game becomes wholesale. The company will not increase trade margins because it does not make much money. The toolkit: gradual direct distribution increase, wholesale demand build-up, and periodic wholesale activations with temporary price reductions.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume recovery | Sequential improvement from Q3; Q4 not back to H1 levels | Q4 FY25; Q1 FY26 for H1-level volumes |
| India margin normalization | Return to 24-26% EBITDA range (approximately 150 bps above current) | Next 6-8 months; lower end of band for full-year FY26 |
| Soap margins | Normalize from current compressed levels | Next 2-3 quarters |
| GAUM organic revenue growth | Turn positive | Q4 FY25 |
| Africa margins | Additional 100-200 bps expansion from approximately 15% | Undated; growth focus now |
| RNF full assessment | Clear read on how well RNF is working | By March (end of Q1 next season) |
| Old-product manufacturing phase-out | Stop manufacturing old formulation for modern trade and e-commerce | By March |
| Raymond margins | Reach 20%-odd first; 25% aspiration is "fullness of time" | Undated |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Consolidated organic revenue growth | 6% in rupee terms |
| Consolidated organic volume growth | Flat |
| Consolidated reported EBITDA growth | -10% |
| India business revenue growth | 4% |
| India business volume growth | Flat |
| India business EBITDA growth | -21% |
| India business EBITDA margin | ~22.5%, normal range expected at 24-26% |
| Soaps EBITDA margin | Just short of 20% |
| Advertising spend | ~10% of sales, held steady |
| Indonesia volume growth | 6% |
| Indonesia revenue growth | 9% |
| Indonesia EBITDA growth | 12% |
| Africa (GAUM) revenue growth | -8% |
| Africa (GAUM) EBITDA growth | 9% |
| GAUM operating margin | ~15%, past 4 quarters; scope for another 100-200 bps increase |
| Latin America volume growth | Greater than 25% |
| Latin America EBITDA margin | Double digits |
| Household Insecticides RNF offtakes in Liquid Vaporizers | 40-50% of end-consumer offtakes |
| Incense Sticks overall market share | High single digits |
| Incense Sticks handler share | Close to 50% |
| Palm oil price decline from peak | ~20%, from MYR5,200 to MYR4,200 |
| PFAD price decline from peak | 7-8% |
| Raymond business EBITDA margin | Mid-teens, up from mid-single digits at acquisition |
| India portfolio structure | ~1/3 Soaps, 1/3 Household Insecticides, 1/3 all others |
| Q4 India margin outlook | More of the same as Q3 |
| Target India margin normalization timeline | Next 6-8 months |
| FY'26 India margin assumption | Lower end of 24-26% (per an analyst's math) |